The challenges and trends of cell & gene therapies
Drug Discovery World
SEPTEMBER 6, 2022
And whilst clinical trials activity decreased by around 15% compared to 2020, last year still saw a number of regenerative medicines reach the bedside. Last year saw the sector surge, with levels of investment hitting an all-time high at $22.7 billion, compared to $19.9 million price point per dose.
Let's personalize your content